These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14604858)

  • 1. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8.
    Reeve JR; Wu SV; Keire DA; Faull K; Chew P; Solomon TE; Green GM; Coskun T
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G395-402. PubMed ID: 14604858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
    Reeve JR; Liddle RA; McVey DC; Vigna SR; Solomon TE; Keire DA; Rosenquist G; Shively JE; Lee TD; Chew P; Green GM; Coskun T
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G326-33. PubMed ID: 15064233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of cholecystokinin (CCK)-B receptor gene did not modify bile or pancreatic secretion or pancreatic growth: a study in CCK-B receptor gene knockout mice.
    Miyasaka K; Shinozaki H; Suzuki S; Sato Y; Kanai S; Masuda M; Jimi A; Nagata A; Matsui T; Noda T; Kono A; Funakoshi A
    Pancreas; 1999 Aug; 19(2):114-8. PubMed ID: 10438156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion.
    Viard E; Zheng Z; Wan S; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G493-500. PubMed ID: 17569741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variation outside the "active" region of dog and rabbit cholecystokinin-58 results in bioactivity differences.
    Reeve JR; Liddle RA; Shively JE; Lee TD; Keire DA; Chew P; Vigna SR
    Pancreas; 2006 Apr; 32(3):306-13. PubMed ID: 16628087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
    Wan S; Coleman FH; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCK-58 is the only detectable endocrine form of cholecystokinin in rat.
    Reeve JR; Green GM; Chew P; Eysselein VE; Keire DA
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G255-65. PubMed ID: 12686511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
    Chowdhury P; Rayford PL
    Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
    Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved.
    Le Dréan G; Le Huërou-Luron I; Gestin M; Romé V; Bernard C; Chayvialle JA; Fourmy D; Guilloteau P
    Can J Physiol Pharmacol; 2000 Oct; 78(10):813-9. PubMed ID: 11077982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin- and gastrin-induced protein and amylase secretion from the parotid gland of the anaesthetized rat.
    Aras HC; Ekström J
    Regul Pept; 2006 May; 134(2-3):89-96. PubMed ID: 16515811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
    Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R
    J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.
    Langmesser S; Cerezo-Guisado MI; Lorenzo MJ; Garcia-Marin LJ; Bragado MJ
    J Cell Biochem; 2007 Mar; 100(4):851-64. PubMed ID: 17226751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages.
    Xu SJ; Gao WJ; Cong B; Yao YX; Gu ZY
    Acta Pharmacol Sin; 2004 Oct; 25(10):1347-53. PubMed ID: 15456538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway.
    Li S; Ni Z; Cong B; Gao W; Xu S; Wang C; Yao Y; Ma C; Ling Y
    Shock; 2007 Jun; 27(6):678-86. PubMed ID: 17505309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M; Liu G; Pinon DI; Miller LJ
    Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor.
    Ghanekar D; Hadac EM; Holicky EL; Miller LJ
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1206-12. PubMed ID: 9316827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
    Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
    Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini.
    Liddle RA; Elashoff J; Reeve JR
    Peptides; 1986; 7(5):723-7. PubMed ID: 2432584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.